PesoRama Announces $25 Million Bought Deal and Filing of Prospectus Supplement Prospectus Supplement and Base Shelf Prospectus Accessible on SEDAR+

Impact · against what's priced in

PesoRama is executing a $25 million equity raise that will significantly dilute existing shareholders. While the cash provides a runway for expansion, the immediate impact is negative due to the issuance of over 41 million new shares at $0.60.

PESO−0.30

No priced-in read yet